Ellsworth Advisors »

Cullinan Oncology shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2026-09-30 $1.1M 75k 15.35

More positions owned by Ellsworth Advisors

Harbor Etf Trust Comm All Wea Etf (HGER)
NVIDIA Corporation (NVDA)
Spdr Gold Tr Gold Shs (GLD)
First Tr Exchange-traded First Tr Enh New (FTSM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Johnson & Johnson (JNJ)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Eaton Corp SHS (ETN)
Alphabet Cap Stk Cl C (GOOG)
Chevron Corporation (CVX)
Cisco Systems (CSCO)
Enterprise Products Partners (EPD)
Amgen (AMGN)

View all positions for Ellsworth Advisors

Top funds holding Cullinan Oncology

MPM Oncology Impact Management
Lynx1 Capital Management
BVF
BlackRock
State Street Corporation
Kynam Capital Management
Vanguard Capital Management
Rtw Investments
Siren
Geode Capital Management
Blue Owl Capital Holdings
VR Adviser
Boothbay Fund Management
Dimensional Fund Advisors
Goldman Sachs Group

View all funds holding Cullinan Oncology